Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Potassium channel openers like minoxidil boost hair growth.

The treatment was ineffective in humans.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Metformin may help treat neuroendocrine tumors.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Two new compounds were found to effectively reduce hair growth in mice.

Some drugs for inflammation may cause psoriasis-like hair loss.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

EGFR inhibitors for lung cancer can cause severe skin issues.